The overall concept within ASTONISH builds on the development and application of common imaging/sensing technologies. Smart algorithms, multimodal fusion techniques and biomedical signal processing will process the acquired data and advanced user interfaces will simplify the complex clinical tasks. These technology components will be integrated to build application specific solutions for physiological signs monitoring, tumour detection, minimally invasive surgery, brain function monitoring and rehabilitation.
Smart algorithms, multimodal fusion techniques and biomedical signal processing will process the acquired data and advanced user interfaces will simplify the complex clinical tasks. These technology components will be integrated together with other conventional imaging technologies to build application-specific solutions for physiological monitoring, tumour detection, minimally invasive surgery, brain function monitoring and rehabilitation.
The technology developed by ASTONISH will allow physicians to record, over a several-days period, highly relevant parameters for the early detection of cardiovascular or metabolic risk. It invests in developing portable devices that will allow for early detection of brain abnormalities, which are now only possible to measure in a hospital environment. Additionally, the project will develop the next generation of medical systems for optical surgical navigation and automated detection of skin cancer using optical biopsy.
The ASTONISH partners cover the full value chain, from semiconductor manufacturing to clinical centres testing the final application. The proposed innovations improve the global competitiveness of the European industry in the healthcare domain and will extend the propositions of the electronic and imaging industry partners resulting in better market position.
